One prominent obesity expert accepted about $1.4 million for consulting and travel between 2013 and 2022, while another received over $1 million tied specifically to Novos weight-loss drugs
Serious Warnings: Both medications carry a "boxed warning" regarding thyroid C-cell tumours
Secondary, safety and negative control endpoints For individual components of the primary endpoint, semaglutide versus sitagliptin reduced myocardial infarction (HR 0.81, 95% CI 0.70 to 0.92) and stroke (HR 0.84, 95% CI 0.71 to 0.99) in the expanded populations at low, moderate and high cardiovascular risk
Furthermore, high glucose levels increase the formation of advanced glycation end products (AGEs) through the non-enzymatic reaction between reducing sugars and cellular proteins, lipids, or nucleic acids
Diet plays a critical role in weight loss